Vanguard Group Inc Indaptus Therapeutics, Inc. Put Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding INDP
# of Institutions
18Shares Held
588KCall Options Held
0Put Options Held
0-
Investment House LLC Las Vegas, NV102KShares$223,3120.01% of portfolio
-
Geode Capital Management, LLC Boston, MA54.8KShares$119,3920.0% of portfolio
-
Strategy Asset Managers LLC45.3KShares$98,8320.02% of portfolio
-
Pine Valley Investments LTD Liability CO Marlton, NJ44.1KShares$96,2360.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny26.1KShares$56,8980.0% of portfolio
About Indaptus Therapeutics, Inc.
- Ticker INDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,258,600
- Market Cap $18M
- Description
- Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...